Developer docs
API playgroundTry for free, no card

Search company profiles

Medclair AB

Full company profile

uuid003hrqz

Namestring
Medclair AB
Legal namestring
Medclair AB
Websiteurl
medclair.com
Company typeenum
Public
Founded yearint
2013
Descriptiontext

Medclair AB is a Swedish cleantech company, founded in 2013 in Borlänge and now headquartered in Stockholm, that specializes in the capture and catalytic decomposition of Nitrous Oxide (N2O) into harmless Nitrogen (N2) and Oxygen (O2). The company targets the climate and occupational risks of N2O — a gas with 273-298x the global warming potential of CO2 — across four sectors: hospitals and maternity wards (anesthesia and pain management), dental clinics (sedation), recycling and waste-management facilities (discarded N2O canisters), and industrial N2O users. Its product portfolio comprises the Mobile Destruction Unit (MDU, >99% destruction rate), the Central Destruction Unit (CDU, >95% purification across multiple treatment rooms), the Recycling Decomposition Unit (RDU, for canister disposal at waste sites), and the EXPO.p / NOD exposure monitors for workplace safety, with an integrated heat-exchanger design that reduces energy consumption after initial heating.

The core technology is a proprietary catalytic process operating at high temperature, validated by IVL Swedish Environmental Research Institute, and protected through know-how rather than a published patent portfolio. The company monetizes primarily through one-time capital-equipment sales of MDU, CDU, and RDU units, supplemented by monitoring hardware (EXPO.p, NOD) and a recurring service and support contract layer for maintenance, spare parts, and technical assistance. Pricing is quote-based and tailored to facility requirements, with multi-year enterprise contracts sold through a direct sales team and an international distributor network across more than 20 countries.

Medclair was listed on the NGM Nordic SME stock exchange in 2017 and operates as an independent Swedish firm under CEO Jonas Lundh, with co-founder Jerker Sundling as CTO and Olesya Nikonova as Chief R&D Officer. It reports 150+ hospital installations globally and flagship enterprise accounts including Hvidovre Hospital (Denmark), Royal Victoria Infirmary (UK NHS), Eastman Institute (Sweden), SUEZ, and Veolia. Leadership has publicly articulated a tenfold growth ambition, supported by recent expansion into the recycling vertical via the RDU and a global destruction capacity of approximately 492,000 tonnes CO2e in 2025.

Short descriptiontext

Medclair AB is a Swedish cleantech firm that builds catalytic decomposition systems and exposure monitors to convert medical and industrial nitrous oxide emissions into harmless nitrogen and oxygen. The company serves hospitals, dental clinics, recycling facilities, and industrial N2O users globally via direct sales and distributors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersStockholm, Sweden
HQ citystring
Stockholm
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nitrous oxide destruction, medical gas capture systems, hospital emission control, catalytic gas decomposition, workplace exposure monitoring
Industry2 codes
PRIMARYIMAHAEAK
Emission Control & Scrubbing Equipment (Scrubbers, Dust Collectors, Catalytic Systems)
SECONDARYEUAHAGAA
Airborne Chemical Exposure Monitoring (VOCs, Solvents, Gases)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Industrial Hygiene & Occupational Exposure Monitoring
NAICS code1 code
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
Product category
Emission Control Equipment
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Sales - Destruction Units
TypeOne Time License
Description

Medclair generates revenue primarily through the sale of N2O destruction hardware systems including Mobile Destruction Units (MDU), Central Destruction Units (CDU), and Recycling Decomposition Units (RDU). These are capital equipment purchases for healthcare facilities, dental clinics, and recycling stations.

medclair.com
2Monitoring Equipment Sales
TypeOne Time License
Description

Sale of EXPO.p exposure monitors and NOD (Nitrous Oxide Detector) devices for workplace safety monitoring in healthcare and industrial settings.

medclair.com
3Service and Support
TypeSubscription Recurring
Description

Full service commitment and ongoing support for customers, including maintenance, spare parts, and technical assistance for installed systems.

medclair.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom enterprise pricing via direct sales
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is quote-based and tailored to facility requirements, scale, and configuration. Contact with sales team (+46 10 510 01 20) or via website 'Talk to an Expert' form required.

medclair.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1EXPO.p
Description

Next-generation N2O exposure monitor with real-time alarms, personal logging, and reliable warning system for workplace safety.

medclair.com
+3 more records
Core offering1 text field

Medclair designs, manufactures, and sells catalytic Nitrous Oxide (N2O) destruction units and exposure monitors that capture and decompose N2O emissions into harmless Nitrogen and Oxygen. The portfolio includes the Mobile Destruction Unit (MDU), Central Destruction Unit (CDU), Recycling Decomposition Unit (RDU), and EXPO.p exposure monitor, sold primarily to hospitals, dental clinics, and recycling operators.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Over 99% N2O elimination rate for Mobile and Recycling Destruction Units
+3 more records
Product overview1 text field

Medclair AB offers a suite of Safe and Sustainable Nitrous Oxide (N2O) management systems designed to capture and decompose N2O into harmless Nitrogen and Oxygen. The product portfolio includes four core offerings: the Mobile Destruction Unit (MDU) for mobile healthcare use, the Central Destruction Unit (CDU) for centralized multi-room hospital installations, the EXPO.p for workplace N2O exposure monitoring with real-time alarms and data logging, and the Recycling Decomposition Unit (RDU) for safe handling of N2O canisters at recycling facilities. These systems work together to address the complete chain of safe and sustainable N2O use across healthcare, dentistry, and recycling sectors, protecting both people and the environment from the harmful effects of N2O emissions.

Product and service4 records
1Mobile Destruction Unit (MDU)
CategoryN2O Destruction Equipment
Description

A mobile N2O destruction unit for healthcare settings that captures exhaled Nitrous Oxide from patients via connected masks or mouthpieces and decomposes it catalytically into Nitrogen and Oxygen, transforming above 99% of N2O. Features integrated monitoring and automatic shutdown protection and can be relocated between treatment rooms.

2Central Destruction Unit (CDU)
CategoryN2O Destruction Equipment
Description

A centralized N2O destruction system designed to manage emissions from multiple treatment rooms simultaneously, using a catalytic process to purify over 95% of Nitrous Oxide into harmless Nitrogen and Oxygen. Includes real-time emission monitoring and an energy-recycling technique that minimizes consumption.

3EXPO.p Nitrous Oxide Exposure Monitor
CategoryGas Detection and Exposure Monitoring
Description

A next-generation N2O workplace exposure monitor using advanced infrared sensor technology to measure gas absorption, providing real-time visual and audio alarms when exposure thresholds are exceeded and personal logging of exposure data. Compact and durable for all-day wear in healthcare and industrial environments.

4Recycling Decomposition Unit (RDU)
CategoryN2O Destruction Equipment
Description

A self-supporting N2O decomposition system for recycling facilities that collects Nitrous Oxide from discarded canisters and catalytically decomposes over 99% of incoming N2O with minimal energy consumption and low noise. The standard model decomposes 360g of N2O per hour and attaches to a wagon with capacity for 26 connected canisters.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Unique partnership between SUEZ, French local authorities, and Medclair that utilizes innovative gas destruction technology to eliminate industrial and environmental risks of discarded nitrous oxide canisters at recycling facilities.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Veolia, a major environmental services company, partnered with Medclair to become the first in the UK to introduce a safe and sustainable method for processing nitrous oxide canisters at recycling facilities.

3Grønnköpingkið University Hospital (World's Greenest Hospital)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Medclair's solutions are featured as part of Grønnköpingkið University Hospital, which claims to be the World's Greenest Hospital initiative, demonstrating the company's integration into flagship sustainable healthcare projects.

medclair.com
Strategic tierCoreTypeGTM or Marketing Partner
Description

Medclair is a member of the Nordic Centre for Sustainable Healthcare, a network promoting sustainable healthcare solutions across the Nordic region.

Strategic tierCoreTypeGTM or Marketing Partner
Description

Medclair is a member of Swecare, a Swedish healthcare industry association supporting internationalization and networking for Swedish healthcare companies.

Strategic tierCoreTypeTechnology or Integration
Description

Third-party validation of Mobile Destruction Unit conducted by IVL Swedish Environmental Research Institute, providing independent scientific verification of destruction efficiency claims.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Chart Industries manufactures cryogenic and gas processing equipment for industrial, medical, and energy applications, including specialty gas handling. Comparable because Chart operates in the gas processing equipment space that overlaps with Medclair's catalytic decomposition technology.

2Drägerwerk
TypeDirect peer
Description

Drägerwerk is a German medical and safety technology company that manufactures anesthesia delivery systems, patient monitoring, and gas detection equipment for hospitals. Comparable to Medclair because both serve the same clinical and workplace safety use cases around inhaled anesthetics and N2O in hospitals.

TypeBroad incumbent
Description

GE HealthCare manufactures anesthesia delivery machines and patient monitoring systems used in hospitals worldwide. Comparable because both companies serve hospital anesthesia and perioperative workflows, though GE HealthCare operates across a much broader portfolio.

TypeDirect peer
Description

Mindray is a Chinese medical device manufacturer that produces anesthesia machines, patient monitors, and related equipment for global hospital markets. Comparable because Mindray competes with Medclair's healthcare customers on adjacent anesthesia and monitoring product categories.

TypeRegional player
Description

Stericycle is a US-focused regulated waste management company providing medical and hazardous waste collection and disposal services. Comparable because Stericycle addresses regulated medical and industrial waste streams that overlap with Medclair's RDU canister handling use case, but primarily serves North America.

TypeBroad incumbent
Description

Linde is one of the world's largest industrial gas suppliers, including N2O for medical and food service applications. Comparable because Linde controls the supply side of N2O and has the customer relationships and balance sheet to enter downstream destruction or recovery.

TypeBroad incumbent
Description

Baxter is a large medical products and pharmaceuticals company that supplies N2O for anesthesia as part of its medical gases portfolio. Comparable because Baxter sits at the supply side of the same N2O value chain Medclair addresses at the destruction and monitoring end.

TypeBroad incumbent
Description

Air Liquide is a global industrial and medical gas supplier, including N2O products for healthcare and other industries. Comparable because Air Liquide sells N2O into the same hospital customer base Medclair serves on the destruction side.

TypeDirect peer
Description

Penlon is a UK-based manufacturer of anesthesia delivery systems and related medical gas equipment used in hospitals. Comparable because Penlon targets the same anesthesia and gas management workflow Medclair addresses, and is a closer geographic and scale peer than the global anesthesia majors.

TypeOthers
Description

Parker Hannifin manufactures motion and control technologies, including gas filtration, separation, and analytical instruments used in industrial and emissions applications. Comparable as an enabling technology provider adjacent to Medclair's gas processing and monitoring solutions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability1 record

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Medclair AB

Emission Control Equipmentmedclair.com

Medclair AB is a Swedish cleantech firm that builds catalytic decomposition systems and exposure monitors to convert medical and industrial nitrous oxide emissions into harmless nitrogen and oxygen. The company serves hospitals, dental clinics, recycling facilities, and industrial N2O users globally via direct sales and distributors.

What Medclair AB does

Medclair AB is a Swedish cleantech company, founded in 2013 in Borlänge and now headquartered in Stockholm, that specializes in the capture and catalytic decomposition of Nitrous Oxide (N2O) into harmless Nitrogen (N2) and Oxygen (O2). The company targets the climate and occupational risks of N2O — a gas with 273-298x the global warming potential of CO2 — across four sectors: hospitals and maternity wards (anesthesia and pain management), dental clinics (sedation), recycling and waste-management facilities (discarded N2O canisters), and industrial N2O users. Its product portfolio comprises the Mobile Destruction Unit (MDU, >99% destruction rate), the Central Destruction Unit (CDU, >95% purification across multiple treatment rooms), the Recycling Decomposition Unit (RDU, for canister disposal at waste sites), and the EXPO.p / NOD exposure monitors for workplace safety, with an integrated heat-exchanger design that reduces energy consumption after initial heating.

The core technology is a proprietary catalytic process operating at high temperature, validated by IVL Swedish Environmental Research Institute, and protected through know-how rather than a published patent portfolio. The company monetizes primarily through one-time capital-equipment sales of MDU, CDU, and RDU units, supplemented by monitoring hardware (EXPO.p, NOD) and a recurring service and support contract layer for maintenance, spare parts, and technical assistance. Pricing is quote-based and tailored to facility requirements, with multi-year enterprise contracts sold through a direct sales team and an international distributor network across more than 20 countries.

Medclair was listed on the NGM Nordic SME stock exchange in 2017 and operates as an independent Swedish firm under CEO Jonas Lundh, with co-founder Jerker Sundling as CTO and Olesya Nikonova as Chief R&D Officer. It reports 150+ hospital installations globally and flagship enterprise accounts including Hvidovre Hospital (Denmark), Royal Victoria Infirmary (UK NHS), Eastman Institute (Sweden), SUEZ, and Veolia. Leadership has publicly articulated a tenfold growth ambition, supported by recent expansion into the recycling vertical via the RDU and a global destruction capacity of approximately 492,000 tonnes CO2e in 2025.

Medclair AB firmographics

Firmographics
Name
Medclair AB
Legal name
Medclair AB
Website
https://medclair.com
Company type
Public
Founded year
2013
Operating status
Operating
Headcount range
11–50 employees
Short description
Medclair AB is a Swedish cleantech firm that builds catalytic decomposition systems and exposure monitors to convert medical and industrial nitrous oxide emissions into harmless nitrogen and oxygen. The company serves hospitals, dental clinics, recycling facilities, and industrial N2O users globally via direct sales and distributors.
Ownership category
akta.pro rank

Medclair AB industry classification

Industry
Product category
Emission Control Equipment
NAICS
Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
akta.pro industry
PRIMARYIMAHAEAK
Emission Control & Scrubbing Equipment (Scrubbers, Dust Collectors, Catalytic Systems)
SECONDARYEUAHAGAA
Airborne Chemical Exposure Monitoring (VOCs, Solvents, Gases)
Energy, Utilities & Environment/Environmental Compliance, Monitoring & Consulting/Industrial Hygiene & Occupational Exposure Monitoring

Keywords

  • Nitrous oxide destruction
  • Medical gas capture systems
  • Hospital emission control
  • Catalytic gas decomposition
  • Workplace exposure monitoring

Where Medclair AB is headquartered

Location

Headquarters

HQ city
Stockholm
HQ country
Sweden
HQ region
Europe

Offices2 records

Markets served

Medclair AB business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Hardware Sales - Destruction Units: Medclair generates revenue primarily through the sale of N2O destruction hardware systems including Mobile Destruction Units (MDU), Central Destruction Units (CDU), and Recycling Decomposition Units (RDU). These are capital equipment purchases for healthcare facilities, dental clinics, and recycling stations.
  2. Monitoring Equipment Sales: Sale of EXPO.p exposure monitors and NOD (Nitrous Oxide Detector) devices for workplace safety monitoring in healthcare and industrial settings.
  3. Service and Support: Full service commitment and ongoing support for customers, including maintenance, spare parts, and technical assistance for installed systems.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing via direct sales

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Medclair AB product offering

Product offering

Core offering

Medclair designs, manufactures, and sells catalytic Nitrous Oxide (N2O) destruction units and exposure monitors that capture and decompose N2O emissions into harmless Nitrogen and Oxygen. The portfolio includes the Mobile Destruction Unit (MDU), Central Destruction Unit (CDU), Recycling Decomposition Unit (RDU), and EXPO.p exposure monitor, sold primarily to hospitals, dental clinics, and recycling operators.

Product overview

Medclair AB offers a suite of Safe and Sustainable Nitrous Oxide (N2O) management systems designed to capture and decompose N2O into harmless Nitrogen and Oxygen. The product portfolio includes four core offerings: the Mobile Destruction Unit (MDU) for mobile healthcare use, the Central Destruction Unit (CDU) for centralized multi-room hospital installations, the EXPO.p for workplace N2O exposure monitoring with real-time alarms and data logging, and the Recycling Decomposition Unit (RDU) for safe handling of N2O canisters at recycling facilities. These systems work together to address the complete chain of safe and sustainable N2O use across healthcare, dentistry, and recycling sectors, protecting both people and the environment from the harmful effects of N2O emissions.

Differentiator

Problem solved

Functional benefit

Brands

  • EXPO.p: Next-generation N2O exposure monitor with real-time alarms, personal logging, and reliable warning system for workplace safety.
  • MDU (Mobile Destruction Unit)
  • CDU (Central Destruction Unit)
  • RDU (Recycling Decomposition Unit)

Products and services

  • Mobile Destruction Unit (MDU) A mobile N2O destruction unit for healthcare settings that captures exhaled Nitrous Oxide from patients via connected masks or mouthpieces and decomposes it catalytically into Nitrogen and Oxygen, transforming above 99% of N2O. Features integrated monitoring and automatic shutdown protection and can be relocated between treatment rooms.
  • Central Destruction Unit (CDU) A centralized N2O destruction system designed to manage emissions from multiple treatment rooms simultaneously, using a catalytic process to purify over 95% of Nitrous Oxide into harmless Nitrogen and Oxygen. Includes real-time emission monitoring and an energy-recycling technique that minimizes consumption.
  • EXPO.p Nitrous Oxide Exposure Monitor A next-generation N2O workplace exposure monitor using advanced infrared sensor technology to measure gas absorption, providing real-time visual and audio alarms when exposure thresholds are exceeded and personal logging of exposure data. Compact and durable for all-day wear in healthcare and industrial environments.
  • Recycling Decomposition Unit (RDU) A self-supporting N2O decomposition system for recycling facilities that collects Nitrous Oxide from discarded canisters and catalytically decomposes over 99% of incoming N2O with minimal energy consumption and low noise. The standard model decomposes 360g of N2O per hour and attaches to a wagon with capacity for 26 connected canisters.

Quantifiable outcome

  • Over 99% N2O elimination rate for Mobile and Recycling Destruction Units
  • +3 more outcomes

Companies that use Medclair AB

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Medclair AB technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature4 records

Medclair AB partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship and core.

  • SUEZflagshipStrategic or Co-development PartnerUnique partnership between SUEZ, French local authorities, and Medclair that utilizes innovative gas destruction technology to eliminate industrial and environmental risks of discarded nitrous oxide canisters at recycling facilities.
  • VeoliaflagshipStrategic or Co-development PartnerVeolia, a major environmental services company, partnered with Medclair to become the first in the UK to introduce a safe and sustainable method for processing nitrous oxide canisters at recycling facilities.
  • Grønnköpingkið University Hospital (World's Greenest Hospital)coreStrategic or Co-development PartnerMedclair's solutions are featured as part of Grønnköpingkið University Hospital, which claims to be the World's Greenest Hospital initiative, demonstrating the company's integration into flagship sustainable healthcare projects.
  • Nordic Centre for Sustainable HealthcarecoreGTM or Marketing PartnerMedclair is a member of the Nordic Centre for Sustainable Healthcare, a network promoting sustainable healthcare solutions across the Nordic region.
  • SwecarecoreGTM or Marketing PartnerMedclair is a member of Swecare, a Swedish healthcare industry association supporting internationalization and networking for Swedish healthcare companies.
  • IVL Swedish Environmental Research InstitutecoreTechnology or IntegrationThird-party validation of Mobile Destruction Unit conducted by IVL Swedish Environmental Research Institute, providing independent scientific verification of destruction efficiency claims.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Medclair AB competitors and assessment

Company assessment

Emerging players

  • Chart Industries: Chart Industries manufactures cryogenic and gas processing equipment for industrial, medical, and energy applications, including specialty gas handling. Comparable because Chart operates in the gas processing equipment space that overlaps with Medclair's catalytic decomposition technology.

Direct peers

  • Drägerwerk: Drägerwerk is a German medical and safety technology company that manufactures anesthesia delivery systems, patient monitoring, and gas detection equipment for hospitals. Comparable to Medclair because both serve the same clinical and workplace safety use cases around inhaled anesthetics and N2O in hospitals.
  • Mindray: Mindray is a Chinese medical device manufacturer that produces anesthesia machines, patient monitors, and related equipment for global hospital markets. Comparable because Mindray competes with Medclair's healthcare customers on adjacent anesthesia and monitoring product categories.
  • Penlon: Penlon is a UK-based manufacturer of anesthesia delivery systems and related medical gas equipment used in hospitals. Comparable because Penlon targets the same anesthesia and gas management workflow Medclair addresses, and is a closer geographic and scale peer than the global anesthesia majors.

Broad incumbents

  • GE HealthCare: GE HealthCare manufactures anesthesia delivery machines and patient monitoring systems used in hospitals worldwide. Comparable because both companies serve hospital anesthesia and perioperative workflows, though GE HealthCare operates across a much broader portfolio.
  • Linde plc: Linde is one of the world's largest industrial gas suppliers, including N2O for medical and food service applications. Comparable because Linde controls the supply side of N2O and has the customer relationships and balance sheet to enter downstream destruction or recovery.
  • Baxter International: Baxter is a large medical products and pharmaceuticals company that supplies N2O for anesthesia as part of its medical gases portfolio. Comparable because Baxter sits at the supply side of the same N2O value chain Medclair addresses at the destruction and monitoring end.
  • Air Liquide: Air Liquide is a global industrial and medical gas supplier, including N2O products for healthcare and other industries. Comparable because Air Liquide sells N2O into the same hospital customer base Medclair serves on the destruction side.

Regional players

  • Stericycle: Stericycle is a US-focused regulated waste management company providing medical and hazardous waste collection and disposal services. Comparable because Stericycle addresses regulated medical and industrial waste streams that overlap with Medclair's RDU canister handling use case, but primarily serves North America.

Others

  • Parker Hannifin: Parker Hannifin manufactures motion and control technologies, including gas filtration, separation, and analytical instruments used in industrial and emissions applications. Comparable as an enabling technology provider adjacent to Medclair's gas processing and monitoring solutions.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Medclair AB social profiles

Digital presence

Medclair AB financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medclair AB leadership team

Management profile

Number of profiles

Profiles4 records

Medclair AB funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medclair AB M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medclair AB

What does Medclair AB do?

Medclair designs, manufactures, and sells catalytic Nitrous Oxide (N2O) destruction units and exposure monitors that capture and decompose N2O emissions into harmless Nitrogen and Oxygen. The portfolio includes the Mobile Destruction Unit (MDU), Central Destruction Unit (CDU), Recycling Decomposition Unit (RDU), and EXPO.p exposure monitor, sold primarily to hospitals, dental clinics, and recycling operators.

Is Medclair AB a public or private company?

Medclair AB is a public company. It is classified as public and is currently operating.

When was Medclair AB founded?

Medclair AB was founded in 2013. It employs 11 to 50 people.

Where is Medclair AB based?

Medclair AB is headquartered in Stockholm, Sweden, in the Europe region.

How does Medclair AB make money?

Three revenue lines are on record. Hardware Sales - Destruction Units are the primary driver. The others are monitoring Equipment Sales and service and Support.

Who are Medclair AB's main competitors?

Chart Industries is listed as an emerging player. Direct peers are Drägerwerk, Mindray and Penlon. Broad incumbents are GE HealthCare, Linde plc, Baxter International and Air Liquide. Stericycle is listed as a regional player. Parker Hannifin is listed as an others.

Does Medclair AB have an API?

No public API is recorded for Medclair AB.

What industry is Medclair AB in?

Medclair AB's product category is Emission Control Equipment. Its primary akta.pro industry code is IMAHAEAK, Emission Control & Scrubbing Equipment (Scrubbers, Dust Collectors, Catalytic Systems), with a secondary code of EUAHAGAA, Airborne Chemical Exposure Monitoring (VOCs, Solvents, Gases). Its NAICS code is 3345.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Dagens industriMedclair ökar omsättningen – resultatet halverasMedclair reported Q3 2026 results with revenue up and EBITDA halved to 0.7 million SEK from 1.8 million. The company's third-quarter results show a significant drop in profitability despite revenue growth.Dagens industriMedclair tar brittisk order värd 12 miljonerMedclair has received a new order worth 12 million SEK from a British actor in the recycling sector. The transaction was announced via a press release on August 20, 2026.AInvestMedClair receives a new order worth approximately 12 MSEK in the UKMedClair has received a new order valued at approximately 12 MSEK from a client in the UK. This transaction represents a direct revenue-generating event for the company within the British market.TradingViewMEDCLAIR INTERIM REPORT JANUARY-JUNE 2026Medclair AB reported an interim period for January–June 2026 with order intake of SEK 41.2 million and net sales of SEK 32.5 million, while profit after tax declined to SEK 3.3 million from SEK 6.5 million in the prior year. The company secured significant new contracts, including a deal with Veolia for nitrous oxide destruction systems and a framework agreement with Folktandvården valued at SEK 6 million. Medclair also expanded its international presence with commercial deals in Singapore and New Zealand and announced plans to merge its Swedish subsidiary.Dagens industriProfessorn om rekordboten: ”Sätter praxis”Daniel Stattin, a professor of market and corporate law, stated that the record premium paid by Cint's bidders sets a new precedent for Nasdaq's future acquisition practices. The article also highlights Medclair, a Swedish cleantech company, launching a new generation of nitrous oxide destruction systems to target the US dental market. This expansion aims to capture a portion of a global market potential estimated at 17 billion kronor.TradingViewMedclair adds a new recycling customer in FranceMedclair has received an order valued at over SEK 3 million from a recycling customer in the Île-de-France region of France. This contract includes an integrated solution for measuring, monitoring, and destroying nitrous oxide, along with a service agreement and an option for further deliveries which highlights the demand for their solutions in the recycling sector. Medclair sees strong potential in the French market as a strategic area for growth.Dagens industriMiljardlöften saknar finansieringThe article is a sponsored press release from Medclair announcing the launch of a new generation of nitrous oxide destruction systems designed for greater efficiency and compactness. The company aims to expand into the US dental market, where it identifies a global potential of approximately 17 billion SEK, by shifting from distributor-based sales to direct operations in key markets including Sweden, England, France, Germany, and the USA.